Literature DB >> 12749653

Development of bradycardia during sedation with dexmedetomidine in an infant concurrently receiving digoxin.

John W Berkenbosch1, Joseph D Tobias.   

Abstract

OBJECTIVE: To describe the development of bradycardia during sedation with dexmedetomidine in a patient concurrently receiving digoxin.
DESIGN: Case report.
SETTING: The pediatric intensive care unit of a tertiary care children's hospital. PATIENTS: A 5-wk-old infant with an atrioventricular septal defect requiring sedation during mechanical ventilation for acute respiratory syncytial virus infection.
MEASUREMENTS AND MAIN RESULTS: As part of an ongoing evaluation of dexmedetomidine for sedation in the pediatric intensive care unit, the patient received a loading dose (0.5 microg/kg) followed by an infusion (0.44 microg x kg(-1) x hr(-1)) of dexmedetomidine. Sedation assessments and hemodynamic data were collected at least every 2 hrs. During the loading dose, the patient's heart rate decreased from 133 beats/min per min to 116 beats/min. During the ensuing 13 hrs, the heart rate continued to decrease into the mid 90s, with additional episodes of bradycardia into the 40s and 50s. Within 1 hr of discontinuation of the dexmedetomidine infusion, the baseline heart rate had recovered, and no further episodes of acute bradycardia were noted.
CONCLUSIONS: This case adds to the limited data regarding dexmedetomidine in pediatric critical care and suggests that caution should be used when considering sedation with dexmedetomidine in patients also receiving digoxin.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12749653     DOI: 10.1097/01.PCC.0000059737.86673.28

Source DB:  PubMed          Journal:  Pediatr Crit Care Med        ISSN: 1529-7535            Impact factor:   3.624


  26 in total

Review 1.  Options and Considerations for Procedural Sedation in Pediatric Imaging.

Authors:  John W Berkenbosch
Journal:  Paediatr Drugs       Date:  2015-10       Impact factor: 3.022

2.  Buccal administration of dexmedetomidine as a preanesthetic in children.

Authors:  Yoshio Sakurai; Toru Obata; Akio Odaka; Katsuo Terui; Masanori Tamura; Hideki Miyao
Journal:  J Anesth       Date:  2010-02       Impact factor: 2.078

Review 3.  The pediatric sedation service: who is appropriate to sedate, which medications should I use, who should prescribe the drugs, how do I bill?

Authors:  Keira P Mason
Journal:  Pediatr Radiol       Date:  2008-05

Review 4.  Incidence of bradycardia in pediatric patients receiving dexmedetomidine anesthesia: a meta-analysis.

Authors:  Maowei Gong; Yuanyuan Man; Qiang Fu
Journal:  Int J Clin Pharm       Date:  2016-12-31

Review 5.  Dexmedetomidine: antiarrhythmic effects in the pediatric cardiac patient.

Authors:  Joseph D Tobias; Constantinos Chrysostomou
Journal:  Pediatr Cardiol       Date:  2013-02-24       Impact factor: 1.655

6.  Dexmedetomidine to control agitation and delirium from toxic ingestions in adolescents.

Authors:  Joseph D Tobias
Journal:  J Pediatr Pharmacol Ther       Date:  2010-01

Review 7.  Dose-dependent bradycardia as a rare side effect of corticosteroids: a case report and review of the literature.

Authors:  Döndü Üsküdar Cansu; Erdal Bodakçi; Cengiz Korkmaz
Journal:  Rheumatol Int       Date:  2018-10-01       Impact factor: 2.631

8.  Perioperative care following complex laryngotracheal reconstruction in infants and children.

Authors:  Punkaj Gupta; Joseph D Tobias; Sunali Goyal; Jacob E Kuperstock; Sana F Hashmi; Jennifer Shin; Christopher J Hartnick; Natan Noviski
Journal:  Saudi J Anaesth       Date:  2010-09

9.  Extended infusion of dexmedetomidine to an infant at sixty times the intended rate.

Authors:  Bryan A Max; Keira P Mason
Journal:  Int J Pediatr       Date:  2010-09-08

10.  Effects of Dexmedetomidine-Fentanyl Infusion on Blood Pressure and Heart Rate during Cardiac Surgery in Children.

Authors:  Jyrson Guilherme Klamt; Walter Villela de Andrade Vicente; Luis Vicente Garcia; Cesar Augusto Ferreira
Journal:  Anesthesiol Res Pract       Date:  2010-08-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.